Clinical Drug Experience Knowledgebase

antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)

avatrombopag (7 trials)

emapalumab-lzsg (gamifant) (11 trials)

palifermin (Kepivance) (14 trials)

anakinra (Kineret) (12 trials)

antihemophilic factor viii human (Hemofil M) (2 trials)

antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) (4 trials)

bile-salt-stimulated lipase (4 trials)

bivv001 (Advate) (1 trial)

carboplatin (paraplatin) (6 trials)

cisplatin (platinol) (2 trials)

coagulation factor ix (Recombinant) (Rixubis) (1 trial)

coagulation factor ix (Recombinant), Fc-fusion protein (Alprolix) (4 trials)

cyclophosphamide (cytoxan) (7 trials)

docetaxel (taxotere) (1 trial)

etoposide (vepesid) (2 trials)

fludarabine (fludara) (4 trials)

gemcitabine (gemzar) (4 trials)

human coagulation factor ix (Mononine) (1 trial)

ibritumomab tiuxetan (Zevalin) (3 trials)

ifosfamide (ifex) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

mitoxantrone (novantrone) (1 trial)

nitisinone (orfadin) (5 trials)

oxaliplatin (eloxatin) (1 trial)

paclitaxel (taxol) (14 trials)

pacritinib (Vonjo) (28 trials)

pegcetacoplan (Empaveli) (2 trials)

pixuvri (12 trials)

prednisone (meticorten) (3 trials)

rituximab (rituxan) (10 trials)

vincristine (oncovin) (3 trials)

vinorelbine (navelbine) (2 trials)

allogeneic stem cells (2 trials)

arsenic trioxide (trisenox) (9 trials)

autologous hematopoietic stem cells (1 trial)

axicabtagene ciloleucel (Yescarta) (1 trial)

azacitidine (vidaza) (4 trials)

bendamustine (treanda) (1 trial)

brostallicin (1 trial)

busulfan (Myleran) (2 trials)

bvt.115959 (1 trial)

camptothecin (2 trials)

capecitabine (xeloda) (1 trial)

cetuximab (erbitux) (1 trial)

ct-2584 (1 trial)

cytarabine (cytosar-u) (2 trials)

decitabine (dacogen) (3 trials)

doxorubicin (Doxil) (2 trials)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

leuprolide (lupron) (1 trial)

melphalan (alkeran) (1 trial)

naltrexone (revia) (2 trials)

ni-0101 (1 trial)

ni-0401 (2 trials)

ni-0801 (2 trials)

obinutuzumab (gazyva) (1 trial)

pemetrexed (alimta) (1 trial)

pracinostat (2 trials)

sirolimus (rapamune) (1 trial)

sobi-003 (2 trials)

sulfated oxysterol (2 trials)

symphoglobulin-d (1 trial)

tacrolimus (prograf) (1 trial)

temozolomide (temodar) (1 trial)

thalidomide (Thalomid) (1 trial)

thiotepa (1 trial)

tosedostat (3 trials)

triamcinolone (kenalog) (1 trial)

urea (2 trials)

vitamin c (1 trial)

clarithromycin (biaxin) (1 trial)

cp-870893 (1 trial)

cyanocobalamin (berocca) (1 trial)

daunorubicin (cerubidine) (1 trial)

heparin (liquaemin) (2 trials)

moxifloxacin (avelox) (1 trial)

ni-0701 (1 trial)

ni-1801 (1 trial)

rifampin (1 trial)

sb1578 (1 trial)

sobi002 (1 trial)

sodium chloride (1 trial)